Clinical Trials Browser

Phase 2/3 × NETWORK × Bevacizumab × Clear all

NCT00294359 2007-08-22

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms